StockData
Adlai Nortye Group Ltd. logo

Adlai Nortye Group Ltd. (ANL) stock

ANLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 10, 2026Score 0/30
$9.48−0.55 (-5.48%)

Close on Nov 17, 2026Market cap $379.20MP/E –Yield –

Adlai Nortye price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Adlai Nortye's price to sales ratio was 69.4× on Nov 11, 2026, against 6.4× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202669.4×+62.9
2025Feb 28, 20256.5×−1.2
2024Dec 31, 20247.8×–

More Adlai Nortye figures

See a number that looks wrong?